LifeStance Health Group

LFST on Nasdaq. LifeStance Health Group provides mental health care to patients through clinics and virtual visits paid by insurance. Market value $4.7bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Look carefully before going further

Read the warning sign in its own filings

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
3.8%fair

For every $100 of what the whole company costs, it produced $3.76 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
59.7×full

You pay 59.7 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
-9.1%five-year median

Each dollar kept in the business earns -9 cents a year. Above 10 is good.

Quality score: 48 of 100. Price score: 26 of 100. Our list needs 70 on quality and 60 on price.

$12.12 a share, 154% above its 1-year low

Over the past year the price has ranged from $4.77 to $13.56.

Pays no dividend

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

-0.1
-0.0
-0.1
0.1
0.1
0.2
2021202220232024202512 monthsto Jun '26

Spare cash swings from quarter to quarter here: $174 million in the past 12 months, $110 million in the year to December 2025.

Revenue
$668m$860m$1.1bn$1.3bn$1.4bn
Operating margin
-42.9%-24.5%-17.9%-2.5%1.7%
Debt to equity
0.100.150.200.200.19
Shares outstanding
0.38bn0.38bn0.38bn0.39bn0.38bn

Health checks

  • Free cash flow positive2 of 5 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)7 of 8 checks we could run
  • Profit backed by cash (accruals)Yes
  • Debt0.19× equity
  • Revenue growth, five yearsStrong, 20.9% a year
  • Buying back its own sharesRoughly flat

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $435 million last quarter, up 26% on a year ago.
  • Profit: $24 million, after a loss of $4 million a year ago.
  • It keeps 5 cents of each $1 of sales as operating profit, up from 0 cents a year earlier.
  • Spare cash over the past 12 months: $174 million, up from $120 million.
  • About the same number of shares as a year ago.
  • Debt is $50 million more than cash, down from $97 million a year ago.
  • Sales grew on a year ago in each of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$313m
December 2024$325m
March 2025$333m
June 2025$345m
September 2025$364m
December 2025$382m
March 2026$403m
June 2026$435m
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$709,000
December 2024-$7m
March 2025$709,000
June 2025-$4m
September 2025$1m
December 2025$12m
March 2026$14m
June 2026$24m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
25 February 2026
Next quarterly (estimated, 10-Q)
5 November 2026

Who owns it

2 long-term investors we follow own it, unchanged from 2 last quarter. 287 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

4 investors own more than 5%.

  • TPG GP A, LLC
    Passive investor
    at least 25.7%−3.6 pts
    (filed with 2 related holders)
    Since 30 June 2026
  • FMR LLC
    Passive investor
    at least 15.0%+3.0 pts
    (filed with 1 related holder)
    Since 31 March 2026
  • BlackRock, Inc.
    Passive investor
    10.1%+1.8 pts
    Since 30 September 2026
  • Summit Partners, L.P.
    Passive investor
    at least 6.1%−1.4 pts
    (filed with 5 related holders)
    Since 30 June 2026

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 8 sold $104m, $13m of it under preset trading plans.

  • Paunovich Vukasin
    Chief Technology Officer
    Sold
    Date
    2 September 2026
    Shares
    42,067
    Price
    $12.87
    Value
    $541,402
  • DeLuca Teresa
    Director
    Sold
    Date
    14 August 2026
    Shares
    7,500
    Price
    $12.68
    Value
    $95,100
  • DeLuca Teresa
    Director
    Sold
    Date
    13 August 2026
    Shares
    20,441
    Price
    $12.23
    Value
    $249,993
  • Burdick Kenneth A
    Director
    Sold
    Date
    11 August 2026
    Shares
    500,000
    Price
    $11.51
    Value
    $6m
  • Paunovich Vukasin
    Chief Technology Officer
    Sold
    under a preset trading plan
    Date
    10 August 2026
    Shares
    44,394
    Price
    $10.85
    Value
    $481,675
  • Miller Lisa K
    Chief Operating Officer
    Sold
    under a preset trading plan
    Date
    10 August 2026
    Shares
    47,912
    Price
    $10.85
    Value
    $519,845
  • Bessler Robert
    Director
    Sold
    under a preset trading plan
    Date
    26 June 2026
    Shares
    894,337
    Price
    $10.13
    Value
    $9m
  • Bessler Robert
    Director
    Sold
    Date
    12 May 2026
    Shares
    575,034
    Price
    $8.02
    Value
    $5m
  • Shuey Eric
    Director
    Sold
    Date
    12 May 2026
    Shares
    243,362
    Price
    $8.02
    Value
    $2m
  • BLACK DARREN M.
    Director
    Sold
    Date
    12 May 2026
    Shares
    5,899,661
    Price
    $8.02
    Value
    $47m

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

1 serious warning sign in LifeStance Health Group’s filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 25 Feb 2026, plus the 10-Q filed 6 Aug 2026 and 8 later 8-Ks.

  • Weak checks on its own accounts

    Serious

    The company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.

    “Based upon that evaluation, as a result of the material weaknesses in internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2026 due to the material weaknesses described below.”
    Show the full paragraph
    Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, as a result of the material weaknesses in internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2026 due to the material weaknesses described below.

    From the 10-Q filed 6 August 2026, Part I, Item 4. Controls and Procedures. Read it in the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • It isn't cheap on profits: 59.7× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.